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Abstract
In mammals, many aspects of behavior and physiology, and in particular cellular metabolism, are coordinated by the
circadian timing system. Molecular clocks are thought to rely on negative feedback loops in clock gene expression that
engender oscillations in the accumulation of transcriptional regulatory proteins, such as the orphan receptor REV-ERBa.
Circadian transcription factors then drive daily rhythms in the expression of clock-controlled output genes, for example
genes encoding enzymes and regulators of cellular metabolism. To gain insight into clock output functions of REV-ERBa,w e
carried out genome-wide transcriptome profiling experiments with liver RNA from wild-type mice, Rev-erba knock-out mice,
or REV-ERBa overexpressing mice. On the basis of these genetic loss- and gain-of-function experiments, we concluded that
REV-ERBa participates in the circadian modulation of sterol regulatory element-binding protein (SREBP) activity, and thereby
in the daily expression of SREBP target genes involved in cholesterol and lipid metabolism. This control is exerted via the
cyclic transcription of Insig2, encoding a trans-membrane protein that sequesters SREBP proteins to the endoplasmic
reticulum membranes and thereby interferes with the proteolytic activation of SREBPs in Golgi membranes. REV-ERBa also
participates in the cyclic expression of cholesterol-7a-hydroxylase (CYP7A1), the rate-limiting enzyme in converting
cholesterol to bile acids. Our findings suggest that this control acts via the stimulation of LXR nuclear receptors by cyclically
produced oxysterols. In conclusion, our study suggests that rhythmic cholesterol and bile acid metabolism is not just driven
by alternating feeding–fasting cycles, but also by REV-ERBa, a component of the circadian clockwork circuitry.
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Introduction
Virtually all light-sensitive organisms from cyanobacteria to
humans possess circadian clocks that allow them to anticipate
environmental changes and thus to adapt their behavior and
physiology accordingly. The mammalian circadian timing system
has a hierarchical structure, in that daily light-dark cycles phase-
entrain the master clock in the suprachiasmatic nucleus (SCN),
which in turn synchronizes subsidiary oscillators in most peripheral
cells [1,2]. How the SCN signals to peripheral organs to entrain
their oscillators is still poorly understood, but daily feeding–fasting
cycles,bodytemperatureoscillations,andSCN-controlled circadian
hormone rhythms appear to play a central role in this process [3–6].
In both the SCN and in the periphery, the circadian oscillator is
thought to be based on a negative transcriptional/translational
feedback loop involving multiple clock components, notably
members of the Period (PER1, PER2) and Cryptochrome
(CRY1, CRY2) protein families. These proteins rhythmically
inhibit their own transcription by interfering with the transactiva-
tion potential of CLOCK/NPAS2:BMAL1 heterodimers [2,7].
The circadian transcription of the gene encoding the nuclear
orphan receptor REV-ERBa is regulated by a similar mechanism,
in that it is activated by CLOCK:BMAL1 and repressed by
PER:CRY complexes. The periodic accumulation of REV-ERBa
provokes the cyclic repression of the essential clock gene Bmal1 [8].
REV-ERBa thus couples the so-called positive and negative limbs
PLoS Biology | www.plosbiology.org 1 September 2009 | Volume 7 | Issue 9 | e1000181of the molecular oscillator. Transcriptome profiling studies on
wild-type and mice defective for core oscillator components have
uncovered that the core clock also regulates the rhythmic activity
of circadian output genes, which account for overt circadian
rhythms in physiology and behaviour [9–13]. For example,
CLOCK:BMAL1 in the liver drives the cyclic expression of the
transcription factors of the proline- and acid-rich basic region
leucin zipper (PAR bZIP) family albumin D-site-binding protein
(DBP), thyrotroph embryonic factor (TEF), and hepatic leukemia
factor (HLF), which in turn regulate the transcription of genes
encoding detoxification enzymes [14].
Hepatic cholesterol and bile acid synthesis have long been
known to be subject to circadian regulation [15–17]. During the
activity phase, when animals absorb food, large amounts of
cholesterol are converted into bile acids, which are secreted into
the gut as emulsifiers of lipids. To ensure cholesterol homeostasis,
the intracellular cholesterol pool has to be replenished. Conversion
of cholesterol into bile acid must therefore be tightly coordinated
during the day, and transcription of genes encoding key enzymes
of cholesterol metabolism are indeed highly circadian.
Cholesterol availability is sensed in membranes of the
endoplasmic reticulum (ER) by the sterol regulatory element-
binding protein (SREBP)-cleavage activating protein (SCAP)-
INSIG-SREBP complex. SREBP members belong to the basic
helix-loop-helix leucine zipper (bHLH-LZ) transcription factor
family. While SREBP-2 controls genes involved in cholesterol
synthesis, such as Hmg-CoA reductase (Hmgcr) [18], SREBP-1c
mainly regulates genes implicated in lipogenesis, such as the gene
encoding fatty acid synthase (FAS) [19]. SREBPs are synthesized
as inactive precursors anchored in the ER membrane via two
transmembrane domains, where they bind to the eight-transmem-
brane domain protein SCAP [20]. The ER-resident proteins
INSIG-1 [21] and INSIG-2 [22] are responsible for the sterol-
dependent retention of the SCAP-SREBP complex in the ER.
SCAP and INSIG-2 are cholesterol and oxysterol sensors,
respectively, and can both initiate formation of the SCAP-
SREBP-INSIG ternary complex depending on sterol availability
[23]. At low sterol concentrations, the SCAP-SREBP complex is
released from INSIG proteins and transported to Golgi vesicles,
where the N-terminal SREBP moiety is cleaved. The processed
SREBP protein then translocates to the nucleus and activates the
transcription of genes encoding enzymes involved in fatty acid and
cholesterol synthesis [24].
Cytochrome P450 7a-hydroxylase (CYP7A1) is the rate-limiting
enzyme in bile acid synthesis. Cyp7a1 transcription is governed by
many transcription factors, notably by several nuclear receptors
[25,26]. For example, the two nuclear receptors Liver-X-Receptor
(LXR) and Farnesoid-X-Receptor (FXR) regulate Cyp7a1 expres-
sion depending on the availability of their ligands, which are
themselves derivatives of cholesterol metabolism. LXR binds
oxysterols (whose levels parallel those of cholesterol) and activates
Cyp7a1 transcription [27,28], whereas FXR binds bile acids and
represses Cyp7a1 transcription [29–31]. In addition, Cyp7a1
expression has long been known to oscillate during the day, but
the transcription factors implicated in this circadian transcription
remained controversial.
Here we show that the orphan nuclear receptor REV-ERBa is a
key player in the circadian regulation of cholesterol and bile acid
synthesis by influencing rhythmic SREBP activity and Cyp7a1
expression. Recently, Duez et al. [32] have reported that REV-
ERBa-deficient mice have a low bile acid phenotype. Although
our study is in keeping with this observation, on the basis of our
genetic loss-of-function and gain-of-function studies we propose
different molecular pathways accounting for the bile acid
phenotype.
Results
Identification of Putative REV-ERBa Target Genes by
Affymetrix Microarray Analysis
To gain insight into the physiological functions of REV-ERBa,
we identified REV-ERBa target genes in a genome-wide manner,
using Affymetrix microarray hybridization analysis of liver RNA
from Rev-erba knock-out (Rev-KO) and wild-type (WT) animals
humanely killed at ZT12 (ZT, Zeitgeber time; ZT0, lights on;
ZT12: lights off). At this time point the differences in the
expression of direct REV-ERBa target genes can be expected to
be maximal in Rev-KO versus control animals (see [8] and Figure
S1). Because REV-ERBa acts as a transcriptional repressor,
transcripts specified by direct target genes should be overrepre-
sented in the Rev-KO animals. Transgenic mice that overexpress
hepatic REV-ERBa throughout the day [11] were also examined.
In these animals, referred to as TgRev, direct REV-ERBa target
genes should be expressed at low levels irrespective of the time of
day. Accordingly, indirect target genes with reduced expression in
Rev-KO mice should display constant high levels in TgRev
animals. The differential expression of genes in the livers of WT,
Rev-KO, and TgRev mice is shown in the genome-wide
transcriptome profiling experiments displayed in Figure 1A (see
lists in Tables S1 and S2). As expected, most genes found to be up-
and down-regulated in Rev-KO animals were down- and up-
regulated, respectively, in TgRev mice (Figure 1A, bracket I and
III). Only a subset of genes did not follow this simple scenario and
showed equal regulation in both Rev-KO and TgRev animals
(Figure 1A, bracket II and IV). Mechanistic models potentially
Author Summary
The mammalian circadian timing system has a hierarchical
architecture: a central pacemaker in the brain’s suprachi-
asmatic nucleus (SCN) synchronizes subsidiary oscillators
present in most peripheral cell types. In both SCN neurons
and peripheral cells, circadian oscillators are thought to
rely on two negative feedback loops. A major feedback
loop involves the two cryptochromes CRY1 and CRY2 and
the two period proteins PER1 and PER2, which serve as
transcriptional repressors for their own genes. An acces-
sory feedback loop couples the expression and activity of
the transcriptional activators CLOCK and BMAL1 to the
expression of cryptochrome and period proteins. The
orphan nuclear receptor REV-ERBa is a key player in this
accessory feedback loop, in that it periodically represses
Bmal1 transcription. In liver, molecular clocks mediate the
temporal gating of metabolic processes. Here we demon-
strate that hepatocyte clocks participate in the control of
cholesterol and bile acid homeostasis. According to this
scenario, REV-ERBa shapes the circadian expression
pattern of insulin-induced gene 2 (INSIG2), a resident
protein of the endoplasmic reticulum that interferes with
the proteolytic activation of sterol response element
binding proteins (SREBPs). In turn SREBPs govern the
rhythmic expression of enzymes with key functions in
sterol and fatty acid synthesis. The circadian production of
sterols (in particular oxysterols) may engender the cyclic
activation of LXR nuclear receptors, which serve as critical
activators of Cyp7a1 transcription. CYP7A1, also known as
cholesterol 7a-hydroxylase, catalyzes the rate-limiting step
in bile acid synthesis.
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depicted in Figure S2.
REV-ERBa oscillates with a sharp expression peak in WT
animals. We thus expected that most of the 76 genes (represented
by 97 probe sets) that we identified as up-regulated in Rev-KO
animals at ZT12 (Table S1) would show circadian mRNA
accumulation profiles in WT animals. For the 60 genes
(represented by 81 probe sets) down-regulated in Rev-KO (Table
S2) this is not necessarily expected as they probably represent
indirect REV-ERBa target genes. So far REV-ERBa has only
been described as a transcriptional repressor. Obviously, it cannot
be excluded that REV-ERBa might also function as an activator
on certain target genes, for example by recruiting co-activators.
Indeed, recruitment of both co-activators and co-repressors has
been reported for the related nuclear receptor Retinoic acid
receptor-related Orphan Receptor a (RORa) [33]. We thus
extracted the circadian accumulation profiles of the identified
genes from a comprehensive study of genome-wide circadian
hepatic gene expression at a 1-h resolution that was recently
performed by the Hogenesch laboratory [10] (see also Gene
Expression Omnibus GSE11923 [http://www.ncbi.nlm.nih.gov/
geo] and http://bioinf.itmat.upenn.edu/circa). Using stringent
algorithms, around 1% of the liver transcriptome was circadian in
this analysis, whereas 54% (41 transcripts) of the up-regulated and
43% (26 transcripts) of the down-regulated fractions identified in
our microarray analysis corresponded to circadian genes (Figure
S3). This result confirms that REV-ERBa is predominantly a
regulator of circadian gene expression. The circadian phases of
Figure 1. REV-ERBa controls the temporal nuclear accumulation of SREBP and the transcription of SREBP target genes. (A) Affymetrix-
microarray analysis of liver RNA from mice of various genotypes. The heat map displays transcripts with differential accumulation in WT, Rev-KO, and
TgRev mice. Differentially expressed transcripts of mice with different genotypes are clustered into four classes: class I: Rev-KO.WT$TgRev; class II:
Rev-KO.WT,TgRev; class III: Rev-KO,WT#TgRev; class IV: Rev-KO,WT.TgRev (see also Figure S2). (B) Temporal accumulation of SREBP1c in liver
nuclear extract. (C) Temporal expression of transcripts from selected SREBP1c genes. (D) Temporal expression of transcripts from selected SREBP2
target genes. (E) Temporal expression of Insig2 transcripts. The data displayed in (C–E) were obtained by quantitative (Q) RT-PCR experiments on
whole-cell liver RNA from WT, Rev-KO, and TgRev animals. The data represent the mean6SEM (n=4–6).
doi:10.1371/journal.pbio.1000181.g001
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for direct REV-ERBa targets. The phases of the down-regulated
transcripts were less uniform, possibly reflecting several indirect
mechanisms.
SREBP Pathways Are Impaired in Rev-erba Null Mice
Analysis of the microarray data showed that Rev-erba disruption
led to the misregulation of several genes involved in lipid
metabolism. In particular, known target genes of the cholesterol-
sensing transcription factor SREBP [34] were expressed at lower
levels in Rev-KO animals (Table S2). This suggested that the
INSIG-SCAP-SREBP pathway was temporally misregulated. To
examine this conjecture, we assessed the nuclear accumulation of
SREBP1c in liver at 4-h intervals around the clock. In WT
animals, nuclear SREBP1c protein was highly abundant at ZT12,
but barely detectable at ZT0 and ZT4 (Figure 1B). In Rev-KO
animals, however, the accumulation of SREBP1c in the nucleus
was shifted by 8 h (Figure 1B). This phase-shifted nuclear
SREBP1c protein accumulation in Rev-KO mice correlated with
the phase-shifted expression of SREBP1c target genes, such as Fas,
Elovl6, Fads2, Insig1,o rSrebp1c itself (Figure 1C, left panel). In
TgRev mice, these genes were up-regulated at ZT0 and virtually
unchanged at ZT12, with the exception of Fads2 which was up-
regulated at both time points (Figure 1C). These findings
substantiated the hypothesis that REV-ERBa controlled the
temporal expression of SREBP1c target genes. The altered
expression of Hmgcr, Low density lipoprotein receptor (Ldlr), and
Acetoacetyl-CoA synthetase (Aacs) in Rev-KO and TgRev animals
suggested that the activity of SREBP2 was affected in these
animals as well (Figure 1D), in spite of the apparently normal
Srebp2 mRNA accumulation (Figure S4A).
The altered nuclear accumulation of SREBP1c in livers of Rev-
KO animals could have been due to a misregulation of its mRNA
(and consequently protein) expression (Figure 1C) and/or a delay
in the processing and transport of SREBP1c to the nucleus. To
investigate the latter possibility, we analyzed whether in Rev-KO
mice there were any peculiarities to the SREBP processing
machinery that would explain the delay in nuclear SREBP1c
accumulation. Whereas Insig2a mRNA (coding for the major
INSIG isoform in liver) showed a 7-fold circadian amplitude in
WT livers, it was indeed expressed at constantly high and low
levels in Rev-KO and TgRev mice, respectively (Figure 1E). This
suggested that Insig2a was a bona fide REV-ERBa target gene. We
were unfortunately unable to examine whether corresponding
changes also exist for INSIG2a on the protein level, since the two
commercial anti-INSIG2a antibodies we purchased did not yield
satisfactory results in immunoblot experiments. However, since
INSIG2a is known to be a short-lived protein [35], the oscillation
of Insig2a mRNA very likely also translated to the rhythmic
accumulation of INSIG2a protein in ER membranes. The
expression of Scap mRNA (Figure S4B) and the non-circadian
minor Insig2b isoform (Figure 1E) were not affected in Rev-KO
mice.
REV-ERBa Regulates SREBP1c Target Genes
Independently of the Feeding Regimen
As shown above, REV-ERBa controlled the nuclear accumu-
lation of SREBPs and, thus, the expression of SREBP targets.
However, it has also been shown that these processes are regulated
by fasting–feeding [36], fatty acids [37–39], and insulin [40].
Therefore, we wished to determine if the temporal misregulation
of the SREBP pathway in Rev-KO mice merely reflected altered
feeding rhythms and/or differences in plasma insulin. To this end,
we recorded the time of food consumption in WT and Rev-KO
animals by an infrared detection system; there were no major
differences between the genotypes (Figure 2A).
We then fasted WT and Rev-KO mice for 24 h and measured
the expression of selected SREBP target genes that we had found
to be regulated in Rev-KO mice fed ad libitum at ZT12 (see
Figure 1C). As shown in Figure 2B, fasting-induced repression of
SREBP target genes such as Srebp1c, Fas, Elovl6, and Aacs, also
occurred in the Rev-KO background. Also the fasting-induced up-
regulation of Insig2a [41] reached similar expression levels in Rev-
KO and control animals (Figure 2B). The fold-up-regulation was
obviously less dramatic in the Rev-KO because basal expression
levels in the fed state were already 10-fold higher than in control
animals.
We next fed mice with a high carbohydrate–no fat diet that is
known to induce the expression of lipogenic SREBP1c target genes
such as Srebp1c, Fas, and Elovl6. Again, we measured the effects at
ZT12 in Rev-KO and control mice, and found that diet-
dependent regulation was independent of the genotype
(Figure 2C). In addition, we did not notice any differences in
plasma insulin concentrations between the genotypes at ZT12
(when SREBP target genes are differentially regulated in WT and
Rev-KO mice), at ZT4 (the beginning of the day phase), or at
ZT16 (the beginning of the night phase) (Figure 2D).
These findings suggest that the regulation of the SREBP
pathway is governed by at least two independent processes. In
addition to its regulation by fasting and feeding that has been
described before, the circadian clock, through rhythmic REV-
ERBa accumulation, regulates the SREBP pathway independently
of the feeding regimen.
REV-ERBa Controls Temporal Lipid Accumulation in
Blood and Liver
We wished to determine whether the temporal misregulation of
SREBP1c also translated to corresponding alterations in the
physiology of Rev-KO mice. SREBP1c target genes are implicated
in the control of triglyceride synthesis in vivo, and Rev-KO mice
indeed showed an altered accumulation of hepatic triglycerides
(Figure 3A). Moreover, AACS and HMGCR are key enzymes in
cholesterol synthesis, and LDLR is responsible for the uptake of
low-density lipoprotein (LDL)-cholesterol from the blood. We
hence measured the hepatic cholesterol and the plasma LDL-
cholesterol in Rev-KO and WT animals. As shown in Figure 3B,
Rev-KO animals had only a modest (albeit statistically significant)
decrease in hepatic cholesterol at ZT12. By contrast, plasma LDL-
cholesterol levels were highly increased in Rev-KO (Figure 3C),
possibly because of a defective LDL-cholesterol uptake by the
LDL-receptor (Figure 1D). We also noticed that HDL-cholesterol
concentrations were augmented in the plasma of Rev-KO animals
specifically at ZT12 (Figure 3D and 3E). Conceivably, increased
HDL-cholesterol levels in Rev-KO mice may have been caused by
down- and up-regulation of the genes encoding endothelial lipase
and apolipoprotein A1 (APOA1), respectively (Figure S5A and
S5B). APOA1 is the major lipoprotein in HDL particles [42], and
endothelial lipase is an enzyme that catabolizes HDL-cholesterol
[43]. However, in contrast to what had been reported previously
[44], we did not notice changes in plasma-VLDL between both
genotypes, and ApocIII mRNA expression in liver was not altered
in our Rev-KO or TgRev mouse models (Figure S5C).
In summary, the misregulation of key enzymes involved in
cholesterol metabolism in the livers of Rev-KO mice correlate well
with the cholesterol phenotype of these animals. We nevertheless
want to point out that extra-hepatic tissues may also have
contributed to the phenotype (see Discussion).
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Accumulation
Cyp7a1 expression has long been known to be circadian [15],
and feeding–fasting rhythms cannot fully account for the daily
oscillations in bile acid synthesis [45]. Thus, the circadian clock
probably contributes to cyclic Cyp7a1 expression directly, thereby
enabling the anticipation of the need for bile acids. As shown in
Figure 4A, both phase and magnitude of Cyp7a1 expression were
severely altered in Rev-KO mice. Moreover, Cyp7a1 mRNA was
constitutively high in TgRev mice (Figure 4B). In Rev-KO
animals, the amount of Cyp7a1 mRNA, integrated over a day, only
represented around 60% of the level seen in the WT animals. To
investigate whether the 40% decrease has a consequence for bile
acid metabolism, we determined the bile acid content in the
gallbladder of Rev-KO animals and found a clear decrease in the
most abundant primary and secondary bile acids cholate and
deoxycholate (Figure 4C). Furthermore, we also noted a general
tendency for other bile acid species to accumulate to lower levels in
the gallbladders of Rev-KO as compared to control animals
(Figure 4C).
REV-ERBa Represses Cyp7a1 Transcription through an
Indirect Mechanism
Although it has been known for more than 30 years that Cyp7a1is
expressed in a circadian fashion, the transcription factors respon-
sible for this regulation are still subject to controversy. Our
observation that diurnal Cyp7a1 was dampened in Rev-KO mice
and constitutively high in TgRev mice strongly indicated that
Cyp7a1 expression was linked to the circadian oscillator by REV-
ERBa. Since REV-ERBa operates as a transcriptional repressor,
Figure 2. Fasting–feeding regulation of SREBP targeted genes in Rev-KO mice. (A) Feeding activity of three Rev-KO and WT mice as
measured by an infrared detection system. (B) Mice that were either fasted for 24 h or (C) fed a high carbohydrate–no fat diet for 18 d were humanely
killed at ZT12, and the accumulation of selected mRNAs was measured in WT and Rev-KO (n=4 per each data point) using Q-RT PCR. (D) Insulin
measurement from blood samples collected at ZT4, ZT12, and ZT16 (n=5 per each data point). (B–D) data represent the mean6SEM.
doi:10.1371/journal.pbio.1000181.g002
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been caused by the down-regulation of a repressor that acts on the
Cyp7a1 gene. Our transcriptome profiling studies revealed the basic
leucine zipper protein E4BP4/NFIL3 as a plausible candidate for
such a repressor (Table S1). As expected for a direct REV-ERBa
target gene, E4bp4/Nfil3 mRNA accumulation oscillated with the
expected phase in WT mice (Figure S6A), and was constitutively
highandlowinRev-KOmiceandTgRevmice,respectively(Figure
S6A and S6B). Temporal E4BP4/NFIL3 protein accumulation was
found to be altered accordingly in WT and Rev-KO mice (Figure
S6C). Since E4BP4/NFIL3 has been shown to repress transcription
through the D-element consensus sequence 59-RTTAGTAAY-39
(Figure S6E) [46], a sequence also bound by the three PAR bZip
transcription factors DBP, HLF, and TEF, it was tempting to
speculate that the E4BP4/NFIL3 repressor and PAR bZip
activators could have antagonistic effects on Cyp7a1 transcription.
In cotransfection experiments, DBP [47–49] and E4BP4/NFIL3
(Figure S6D) indeed activated and repressed, respectively, tran-
scription from the Cyp7a1 promoter in a dose- and D-element-
dependent manner.However, the implication of PAR bZip proteins
or E4BP4 in circadian Cyp7a1 regulation did not withstand scrutiny
by loss-of-function experiments. As shown in Figure 5A, Dbp/Tef/
Hlf triple knock-out (TKO) mice still exhibited circadian Cyp7a1
accumulation levels similar to those of WT animals (Figure 5A). If
E4BP4/NFIL3 directly repressed Cyp7a1 transcription, Cyp7a1
mRNA should accumulate to higher levels in E4bp4/Nfil3-KO mice
at time ZT0, when Cyp7a1 expression is low and E4BP4/NFIL3
protein highly abundant (Figures 4A and S6C). However, we found
that Cyp7a1 mRNA accumulated to similar levels at ZT0 and was
dampened at ZT12 in E4bp4/Nfil3-deficient animals (Figure 5B).
These in vivo data argue against a putative roleof E4BP4/NFIL3as
a direct Cyp7a1 repressor. An indirect role of E4BP4/NFIL3 in
regulating Cyp7a1 appears to exist nevertheless, as judged by the
down-regulation in the E4bp4/Nfil3-KO at ZT12 (a time point
when E4BP4/NFIL3 is barely expressed; see Figure S6C).
It is known that in rodents changes in CYP7A1 activity parallel
those of HMGCR activity, the enzyme that catalyzes the rate-
limiting step in de novo cholesterol synthesis [50]. The specific
inhibition of HMGCR by compounds such as lovastatin results in
decreased Cyp7a1 mRNA accumulation [51,52]. This decrease is
prevented if mice receive the HMGCR inhibitor together with an
infusion of mevalonate, the product of the reaction catalysed by
HMGCR [51,52]. In addition, inhibition of the last step in
cholesterol synthesis by the compound AY9944 also decreases
Cyp7a1 expression [53]. Thus circadian endogenous cholesterol
synthesis [17,54] seems to be linked to the regulation of the Cyp7a1
transcription.
In Rev-KO and TgRev mice the down- and up-regulation of
Hmgcr expression observed at ZT12 and ZT0, respectively
(Figure 1D), can be expected to engender corresponding changes
in oxysterol production [55]. This, in turn, might have an impact
on Cyp7a1 transcription by LXR, which is known to be regulated
by oxysterol availability [56]. It is thus conceivable, if not likely,
that this pathway can impart on circadian Cyp7a1 transcription via
the activation of LXR receptors in spite of unchanged Lxra and
Figure 3. Accumulation of cholesterol and triglycerides in liver
and plasma of WT and Rev-KO mice. (A) Total hepatic triglycerides
and (B) cholesterol in WT mice (ZT12 n=8,ZT20n=6) and Rev-KO mice
(ZT12 n=10, ZT20 n=4). (C) Plasma LDL-cholesterol and (D) HDL-
cholesterol in WT and Rev-KO (n=6 per each data point). (E) Plasma
samples from animals humanely killed at ZT12 and ZT20 were pooled
(n=6) and lipoproteins separated by fast protein liquid chromatography
(FPLC). (A–D) data represent the mean6SEM. p-Values: *, ,0.05; **, ,0.005.
doi:10.1371/journal.pbio.1000181.g003
Figure 4. REV-ERBa controls Cyp7a1 transcription and bile acid
accumulation. (A) Temporal Cyp7a1 mRNA accumulation in the livers
of WT, Rev-KO, and (B) TgRev mice. The data represent the mean6SEM
(n=4–6). (C) Primary and secondary bile acid levels in gallbladders from
WT and Rev-KO mice. Data represent the mean6SEM (n=6). p-Values:
*, ,0.05; **, ,0.005.
doi:10.1371/journal.pbio.1000181.g004
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could be at least in part responsible for circadian Cyp7a1
transcription, we measured Cyp7a1 transcript levels in Lxra/Lxrb
double knock-out mice (LXRa/b) at ZT0 and ZT12. As shown in
Figure 5C, control mice showed a 4-fold amplitude in Cyp7a1
mRNA levels between ZT0 and ZT12, which was absent in
LXRa/b-KO mice. This effect was not due to changes in Rev-erba
levels (unpublished data). Thus, a lack of LXR activation by
oxysterols at ZT12 seemed to be the most likely scenario to explain
the dampened Cyp7a1 mRNA accumulation seen in Rev-KO
mice. Similarly, the up-regulation of Hmgcr seen at ZT0 in TgRev
animals could have led to increased levels of oxysterols and thus an
increase of Cyp7a1 transcription by LXR receptors.
Discussion
The genome-wide transcriptome analysis of livers from mice
carrying Rev-erba loss- and gain-of-function alleles has identified
REV-ERBa as a circadian regulator of cholesterol/lipid and bile
acid homeostasis.
Cholesterol is an essential molecule for membrane fluidity, and
the synthesis of hormones and bile acids. Likewise, bile acids are
required to emulsify absorbed lipids into micelles that are taken up
by epithelial cells of the intestine and transported to the liver and
other target organs. However, excessive cholesterol can lead to
pathologies such as gallstone formation and atherosclerosis. At
elevated concentrations bile acids are cytotoxic, and they can also
function as proliferation signals [57]. To maintain the bile acid/
cholesterol equilibrium, the gene encoding the rate-limiting
enzyme of bile acid synthesis from cholesterol, Cyp7a1, is tightly
regulated. Indeed, a myriad of transcription factors has been
shown to act on its promoter (for review see [25]). While the
regulatory processes are based on substrate and end-product
sensing, Cyp7a1 expression is also known to be subject to circadian
control [15].
Our data suggest that the circadian clock component REV-
ERBa participates in this process. Indeed, we found that REV-
ERBa controls the timing of cyclic accumulation of SREBP in the
nucleus, which in turn regulates the temporal expression of
HMGCR. In Rev-KO mice, Hmgcr misregulation could engender
a diminution of oxysterol production and compromise the LXR-
oxysterol-mediated transcription of Cyp7a1 [56]. Our hypothesis is
supported by the fact that drugs which inhibit HMGCR activity
are known to decrease Cyp7a1 transcription, and that circadian
Cyp7a1 expression is severely blunted in Lxra/b knock-out mice
(Figure 5C). It will be interesting to directly determine hepatic
oxysterol levels in order to support our conjecture that LXR
isoforms drive circadian Cyp7a1 transcription. Unfortunately, as
pointed out by Schroepfer [58], the methods necessary for
measuring oxysterols in a reproducible fashion are still challeng-
ing. In a recent study, Duez and coworkers [32] have postulated
that REV-ERBa regulates Cyp7a1 transcription by repressing the
expression of both E4BP4/NFIL3 and small heterodimer partner
(SHP). In our study, however, we did not observe a strong
misregulation of Shp mRNA accumulation in Rev-KO mice and
actually found higher levels in TgRev mice at both time points
tested (Figure S7). Several previous studies argue against a major
role for SHP in Cyp7a1 regulation as well. First, Cyp7a1 expression
is known to be only mildly up-regulated in livers of Shp knock-out
mice [59]. Moreover, the feedback repression of Cyp7a1 by FXR
agonists has been reported to persist in a mouse model carrying a
hepatocyte-specific disruption of Fxr alleles, despite the lack of Shp
induction [60]. Furthermore, the circadian phase of Shp expression
does not correlate with that of other REV-ERBa target genes. Shp
mRNA accumulation peaks at ZT8 in WT mice; REV-ERBa
target genes are at their trough at this time-point. Hence, we do
not consider REV-ERBa-controlled SHP expression a very likely
mechanism accounting for circadian Cyp7a1 expression.
Our genetic loss-of-function experiments did not support the
role of E4BP4/NFIL3 in circadian Cyp7a1 expression suggested
previously by Duez et al. [32]. Although we observed a similar
repressive activity of E4BP4/NFIL3 on the Cyp7a1 promoter in
co-transfection experiments (Figure S6D; see also [32]), there was
no up-regulation of Cyp7a1 expression in the livers of E4bp4/Nfil3
knock-out mice. Hence, we believe that E4BP4/NFIL3 only
down-regulates Cyp7a1 transcription when overexpressed at
unphysiologically high levels. Gain-of-function studies, which are
notoriously difficult to interpret, have also led to the suggestion
that DBP serves as a circadian activator of Cyp7a1 transcription
[47–49]. Again, this result did not bear up against loss-of-function
data in the corresponding knock-out mice (Figure 5A). We thus
believe that neither E4BP4/NFIL3 nor DBP (or its paralogs TEF
and HLF) play significant roles as direct regulators of circadian
Cyp7a1 expression. Our loss-of-function data, rather, implicate the
nuclear receptors LXRa/b in the circadian regulation of Cyp7a1
transcription, but we are aware that the biochemical dissection of
this network will require additional experiments.
The liver-specificity of the Rev-erba transgene in the TgRev mice
made it unlikely that the misregulation of Cyp7a1 in the liver
originated from a dysfunction outside of this organ. We
nevertheless decided to analyze the expression of Fgf15 in Rev-
KO mice, as it is known that this hormone is intestinally produced
Figure 5. LXR participates in the circadian transcription of Cyp7a1. Temporal Cyp7a1 mRNA accumulation was measured in the livers of (A)
Dbp/Tef/Hlf triple knock-out mice (B) E4bp4/Nfil3 knock-out mice and (C) LXRa/b double knock-out animals. Data represent the mean6SEM (n=4).
doi:10.1371/journal.pbio.1000181.g005
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recent publication showed that in humans, circulating FGF19 (the
homologue of FGF15) has a diurnal variation [61]. We found
Fgf15 to be expressed at similar levels in the intestines of WT and
Rev-KO mice (Figure S8). Despite an induction of expression at
ZT12, Fgf15 mRNA levels did not display robust circadian
oscillations.
The circadian utilization of cholesterol for bile acid synthesis
must be counterbalanced by cholesterol synthesis and uptake in
order to maintain stable cholesterol levels. In principle, the sterol-
dependent processing and activation of the cholesterol-sensing
transcription factor SREBP might be expected to suffice for this
purpose. However, our study indicates that SREBP processing is
also under circadian control exerted by REV-ERBa. Thus, REV-
ERBa governs the rhythmic abundance of INSIG2, which in turn
influences the diurnal translocation of SREBP to the nucleus
where it transactivates its target genes. Interestingly, FXR has
been previously shown to transactivate Insig2a expression at the
beginning of the light phase [62] and therefore it would be
interesting to test the contribution of this nuclear receptor in the
circadian regulation of Insig2a transcription. Thus, FXR and
REV-ERBa, by activating and repressing Insig2a transcription,
respectively, could act antagonistically on the SREBP pathway.
We found that nuclear SREBP accumulation and target gene
expression were misregulated in Rev-KO mice despite indistin-
guishable feeding rhythms, fasting responses, and insulin levels.
This finding strongly suggests that REV-ERBa and the circadian
clock impact the SREBP pathway by a more direct mechanism. At
ZT12, when animals start to feed, REV-ERBa represses Insig2a,
and SREBP strongly accumulates in the nucleus. Subsequently
Hmgcr transcription is induced, and cholesterol synthesis will peak
shortly thereafter, together with Cyp7a1 transcription. Through
this elaborate control of timing, the bile acid pool will be
replenished in coordination with food uptake. Bile acids will thus
be sufficiently available to emulsify dietary lipids.
In addition, our transcriptome analysis of Rev-KO mice points to
a broader role for this nuclear receptor as a circadian regulator of
lipid metabolism. REV-ERBa regulates genes such as Elovl3, Elovl5,
Lipoprotein lipase, Fatty acid binding protein 5, Acyl-CoA thioesterase 3,o r
Phosphatidylcholine transfer protein (Figure S9). Moreover, we have
recently shown that REV-ERBa participates in the transcription of
the liver-specific miRNA miR-122 [63]. This miRNA is known to
function in lipid and cholesterol metabolism [64,65].
Finally, our in vivo studies do not support the view that REV-
ERBa plays a key role in glucose homeostasis, a hypothesis recently
proposed by work with HepG2 cells [66]. Although we did notice a
mild hyperglycemia at ZT12 in Rev-KO mice (Figure S10E), the
circadian expression of Phosphoenol pyruvate carboxykinase (Pepck)w a s
nearly unaltered, and that of Glucose 6-phosphatase (G6pase) was only
moderatelyaffected (FigureS10AandS10B).Moreover,thesegenes
were not significantly repressed by overexpressed REV-ERBa
(Figure S10A and S10B). In addition, the expression of Glucokinase
(Gk) was not affected by Rev-erba loss- and gain-of-function (Figure
S10C). Most importantly, no notable differences in blood glucose
clearance were observed between WT and Rev-KO mice upon
intraperitoneal glucose injection (Figure S10D). Possible explana-
tions for this discrepancy may lie in species-specific functions of
REV-ERBa and/or the difficulty to extrapolate from in vitro or
tissue culture studies to physiology in the animal.
In conclusion, the data presented in this study suggest that the
circadian orphan nuclear receptor REV-ERBa modulates lipid and
bile acid metabolism by affecting the SREBP pathway and the
regulation of Cyp7a1 transcription (Figure 6). Our studies, together with
work on the substrate-sensing nuclear receptors [67,68], exemplify how
the circadian clock can cooperate with inducible regulatory mecha-
nisms in the daily tuning of lipid and bile acid homeostasis.
Materials and Methods
Animal Care and Treatment
All animal studies were conducted in accordance with the
regulations of the veterinary office of the State of Geneva and
Dutch and Austrian regulations according to criteria outlined in
the Guide for the Care and Use of Laboratory Animals prepared
by the National Academy of Sciences, as published by the
National Institutes of Health. Rev-KO mice have been previously
described [8]. Transgenic mice that overexpress hepatic REV-
ERBa contain two transgenes [11]. Briefly, the first transgene
encodes an HA-epitope-tagged REV-ERBa cDNA controlled by a
tetracycline responsive element and the second one expresses a
hepatocyte-specific tetracycline-dependent transactivator. In the
presence of doxycycline (Dox), transactivator binding is inhibited
and thus the Rev-erba transgene remains silent. Dox-fed mice or
mice containing only one of the two transgenes were used as
control animals. Lxra/Lxrb double knock-out and Dbp/Tef/Hlf
triple knock-out have been previously described [69,70]. The
E4bp4/Nfil3 knock-out mice have been generated by the
Figure 6. The role of REV-ERBa in circadian lipid and bile acid
homeostasis. The cartoon illustrates how REV-ERBa may modulate
circadian lipid, cholesterol, and bile acid synthesis by controlling the
accumulation of SREBP in the nucleus. In liver hepatocytes, REV-ERBa
accumulates to maximal levels at ZT8–ZT12 and represses Insig2
transcription. Thereby, it promotes the proteolytic activation and
nuclear accumulation of SREBP proteins. In turn, the circadian activation
of SREBP transcription factors drives the cyclic transcription of Hmgcr,
encoding the rate-limiting enzyme of cholesterol biosynthesis. As a
consequence the levels of oxysterols, which serve as ligands for LXR,
also oscillate during the day, and cyclically activated LXR then controls
rhythmic Cyp7a1 transcription.
doi:10.1371/journal.pbio.1000181.g006
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Oncology, Dana-Farber Cancer Institute, Harvard Medical
School, Boston, Massachusetts). Briefly, exon 2 of the E4bp4/
Nfil3 gene that contains the full coding sequence has been replaced
by a neomycin cassette (A.T. Look, personal communication). As
expected, no E4bp4/Nfil3 mRNA could be detected in these mice,
see Figure S11. Except for Figure 2B and 2C where mice were
fasted for 24 h or were fed a high carbohydrate–no fat diet
(Harlan Teklad TD03314), animals received a normal chow diet.
Mice were maintained under standard animal housing conditions
(12-h light/12-h dark cycle), with free access to food and water.
Affymetrix Oligonucleotide Microarray Hybridization
Whole-cell liver RNAs from 18 WT and 18 Rev-KO animals
(3–4 mo old) humanely killed at ZT12 were used. Three RNA
pools of six mice per pool were assembled by mixing equal
amounts of RNA. For liver-specific transgenic Rev-erba mice, six
animals each for Dox-treated and untreated mice were humanely
killed at ZT12 and whole-cell liver RNA was extracted from each
animal. Two RNA pools of three animals were assembled by
mixing equal amounts of RNA. For Rev-KO, TgRev and WT
control animals, 5 mg of pooled RNA were employed for the
synthesis of biotinylated cRNA, and 8.75 mg of this cRNA were
hybridized to Affymetrix Mouse Genome 430 2.0 array (according
to the Affymetrix protocol). To identify differentially expressed
transcripts, pairwise comparisons were carried out using Affyme-
trix GCOS 1.2 software. In the Rev-KO versus WT mice
experiment, each of the three experimental samples was compared
to each of the three reference samples, resulting in nine pairwise
comparisons. This approach is based on the Mann-Whitney
pairwise comparison test and allows the ranking of results by
concordance, as well as the calculation of significance (p-value) for
each identified change in gene expression [71,72]. Genes for
which the concordance in the pairwise comparisons exceeded the
imposed threshold of 77% (seven out of nine comparisons) were
considered to be statistically significant. In addition, we only
selected transcripts whose accumulation had an average change of
at least 1.5-fold. For these selected probe sets microarray data for
the transgenic Rev-erba mice was then extracted (Figure 1A) from
the study reported in Kornmann et al. [11].
Quantitative Reverse Transcriptase-PCR Analysis
cDNA was synthesized from 1 mg of liver whole-cell RNA using
random hexamers and Superscript II reverse transcriptase (RT)
(Invitrogen) following the supplier’s instructions. Five percent of
this cDNA was PCR amplified (7900HT Sequence Detection
Systems, Applied Biosystems) by using the Sybr Green master mix
(Applied Biosystems), and raw threshold-cycle (Ct) values were
calculated with SDS 2.0 software (Applied Biosystems). Mean
values were calculated from triplicate PCR assays for each sample
and normalized to those obtained for Cyclophillin and Eef1a1
transcripts, which served as internal controls [73]. For a list of
primers used in this study, see Table S3.
Western Blotting
Nuclear extracts were prepared by the NUN procedure as
described previously [47], and Western blotting was performed
according to standard protocols using a mouse anti-SREBP1
monoclonal antibody (BD Biosciences 557036).
Blood Chemistry
Blood samples were collected at Zeitgeber times 12 and 20 (ZT12
and ZT20) in lithium heparin containing tubes (BD Microtainer)
and centrifuged for 10 min at 4,500 rpm. Plasma supernatants
were kept frozen at 220uC. The levels of HDL- and LDL-
cholesterol were measured using a Roche-diagnostics Enzymatic
kit for the Hitachi 902 robot according to the manufacturer’s
instruction. For Rev-KO mice and WT animals (humanely killed
at ZT12 and 20) plasma samples were pooled (n=6) and
lipoproteins separated by fast protein liquid chromatography
(FPLC) on a Superose 6B 10/30 column (Amersham Bioscience).
The level of insulin was measured using an ELISA kit (Mercodia
10-1150-01) according to the manufacturer’s instruction, from
blood samples collected at ZT4, ZT12, and ZT16.
Bile Analysis
Mice were anesthetized by intraperitoneal injection of Hyp-
norm (fentanyl/fluanisone 1 ml/kg) and diazepam (10 mg/kg).
Bile was collected during 30 min by cannulation of the
gallbladder, and total bile acids were measured enzymatically
[74]. Total gallbladder cholesterol was measured according to
Kruth et al [75]. For the determination of specific bile acid species,
bile acids extracted from bile [76] were analyzed by gas
chromatography mass spectrometry (GC-MS).
Hepatic Cholesterol and Triglycerides
Livers were homogenized and lipids extracted as described by
Bligh and Dyer [76]. Hepatic triglyceride and cholesterol
concentrations were measured using an enzymatic kit (Roche
Molecular Biochemicals, Mannheim, Germany) according to the
manufacturer’s instruction.
Accession Numbers
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank) acces-
sion numbers for the genes and gene products discussed in
this paper are Aacs (NM_030210); Acot3 (NM_134246); Apoa1
(NM_009692); ApoCIII (NM_023114);Bmal1(NM_007489); Cyp7a1
(NM_007824); Dbp (NM_016974); E4bp4/Nfil3 (NM_017373);
Elovl3 (NM_007703); Elovl5 (NM_134255); Elovl6 (NM_130450);
Fabp5 (NM_010634); Fads2 (NM_019699); Fas (NM_007988); Fgf15
(NM_008003); G6pc (NM_008061); Glucokinase (NM_010292); Hlf
(NM_172563); Hmgcr (NM_008255); Insig1 (NM_153526); Insig2
(NM_133748); Ldlr (NM_010700); Lipase endothelial (NM_010720);
Lpl (NM_008509); Lxra (NM_013839); Lxrb (NM_009473); Pctp
(NM_008796); Pepck (NM_011044); Rev-erba (NM_145434); Scap
(NM_001001144); Shp (NM_011850); Srebp1 (NM_011480); Srebp2
(NM_033218); Tef (NM_017376).
The ArrayExpressrepository(http://www.ebi.ac.uk/arrayexpress)
accession number for the microarray data is E-TABM-726.
Supporting Information
Figure S1 Temporal expression of Rev-erba and Bmal1
mRNA in liver of WT and Rev-KO mice, as monitored by
quantitative RT-PCR. mRNA levels were determined around
the clock from pooled whole-cell RNAs (four to six animals per
time point).
Found at: doi:10.1371/journal.pbio.1000181.s001 (0.45 MB EPS)
Figure S2 Possible mechanisms accounting for the four
major expression patterns identified in Figure 1A. In the
left diagrams, target gene expression (y-axis) is schematically
plotted against REV-ERBa concentration. The diagrams to the
right depict possible protein-DNA and protein-protein interactions
that might account for the observed expression patterns. Class I:
The genes belonging to this class are likely to be direct REV-
ERBa targets. Their expression is upregulated in the Rev-KO
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compared to WT mice. Class II: These genes may also be direct
REV-ERBa targets, but their transcription is less efficiently
repressed in an excess of REV-ERBa. Conceivably, unsuccessful
competition of promoter-bound REV-ERBa with free REV-
ERBa (or REV-ERBa bound nonspecifically to other DNA
sequences) for corepressor complexes may account for the
derepression at high REV-ERBa concentrations. The competition
of promoter-bound and unbound transcriptional regulators for
rate-limiting cofactors was termed squelching by Gill and Ptashne
[77]. Class III: The transcription of these genes is indirectly
regulated by REV-ERBa, because of the down regulation of a
repressor (i.e., E4BP4/NFIL3). Class IV: Indirect REV-ERBa
target genes (see class III) whose repressor is encoded by a class II
gene (i.e., squelched at high REV-ERBa concentrations).
Obviously, many other, more complex mechanisms may also
account for the expression patterns of class II and class IV
transcripts.
Found at: doi:10.1371/journal.pbio.1000181.s002 (0.74 MB EPS)
Figure S3 Analysis of circadian mRNA accumulation
profiles of the genes found to be up- and down-regulated
in Rev-KO mice. Temporal accumulation patterns of the 76 and
60 transcripts listed in Tables S1 and S2 (represented by 97 and 81
probe sets, respectively) that were found to be $1.5-fold up- and
down-regulated in Rev-KO mice at ZT12. These profiles were
retrieved from the Gene Expression Omnibus GSE11923 and
http://bioinf.itmat.upenn.edu/circa database [10]. This database
contains the circadian analysis of the hepatic transcriptome at a 1-
h resolution. (A) Phase distribution of the 454 probe sets found to
be circadian in WT mice. (B) Phase distribution of the 56 and (C)
35 probe sets found to be up- or down-regulated in Rev-KO mice
and circadian in WT animals (with an amplitude of $2, see
Kornmann et al. for details [11]). The up- and down-regulated
probe sets in Rev-KO mice are enriched 55- and 43-fold,
respectively, in circadian probe sets (p,10
210).
Found at: doi:10.1371/journal.pbio.1000181.s003 (0.40 MB EPS)
Figure S4 Temporal hepatic expression of transcripts
specified by (A) Srebp2, (B) Scap, and (C) Lxra and Lxrb
in WT and Rev-KO mice, as monitored by quantitative
RT-PCR. mRNA levels were determined around the clock from
pooled whole-cell RNAs (four to six animals per time point).
Found at: doi:10.1371/journal.pbio.1000181.s004 (0.53 MB EPS)
Figure S5 Temporal hepatic expression of transcripts
specified by (A) Lipase endothelial, (B) Apoa1, (C) Apoc3
in WT, Rev-KO, and TgRev mice. In the left panels mRNA
levels were quantified as described in the legend to Figure S4. The
right histograms show mean values6standard error of the mean
(SEM) obtained from individual animals at ZT0 and ZT12 (n=3
for WT mice, and n=4 for TgRev mice).
Found at: doi:10.1371/journal.pbio.1000181.s005 (0.43 MB EPS)
Figure S6 REV-ERBa controls the circadian expression
of the E4bp4/Nfil3 repressor. Temporal E4bp4/Nfil3 mRNA
accumulation in the livers of (A) Rev-KO and (B) TgRev mice. (C)
Immunoblot analysis of E4BP4/NFIL3 accumulation at ZT0,
ZT4, ZT8, ZT12, ZT16, and ZT20 in livers of WT and Rev-KO
mice. The same blot was probed with an antibody against the
constitutively expressed splicing factor U2AF
65 (loading control).
(D) Cotransfection of an E4BP4/NFIL3 expression vector with
Cyp7a1-luciferase reporter genes harboring an intact D-element
(black columns) or two mutated D-elements (mut1, white columns;
mut2, grey columns). The sequences of intact D-elements and
mutated D-elements are depicted in (E).
Found at: doi:10.1371/journal.pbio.1000181.s006 (1.75 MB EPS)
Figure S7 Temporal hepatic expression of transcripts
specified by the SHP in WT, Rev-KO, and TgRev mice. In
the left panels mRNA levels were quantified as described in the
legend to Figure S4. The right histogram shows mean values6SEM
obtained for individual animals at ZT0 and ZT12 (n=3 for WT
mice, and n=4 for TgRev mice).
Found at: doi:10.1371/journal.pbio.1000181.s007 (0.47 MB EPS)
Figure S8 Temporal intestinal (Ileum) expression of
transcripts specified by the fibroblast growth factor 15
in WT and Rev-KO, as monitored by quantitative RT-
PCR. mRNA levels were determined around the clock.
The data are represented as mean values6SEM (n=4 animals per
time point).
Found at: doi:10.1371/journal.pbio.1000181.s008 (0.31 MB EPS)
Figure S9 Expression of genes involved in hepatic lipid
metabolism and transport in WT and Rev-KO mice. The
temporal hepatic expression of transcripts was determined by
Northern blot hybridization (Elovl3 and Elovl5), or quantitative
RT-PCR (Lpl, Fabp5, Pctp, Acot3) from pooled whole-cell RNAs
from four to six animals per time point.
Found at: doi:10.1371/journal.pbio.1000181.s009 (2.83 MB EPS)
Figure S10 REV-ERBa plays a minor role in glucose
homeostasis. Temporal expression of (A) Pepck, (B) G6pc, and (C)
Gk mRNA in liver of WT, Rev-KO, and TgRev mice. (A–C), left
panels, mRNA levels were determined around the clock from
pooled whole-cell RNAs (four to six animals per time point) or (A–
C), right panel, from individual animals at ZT0 and ZT12 (data
represent mean values6SEM; WT, n=3; TgRev, n=4). (D)
Glucose tolerance test on WT and Rev-KO mice (data represent
mean values6SEM, n=9). (E) Blood glucose concentration
determined at ZT12 and ZT20 for WT and Rev-KO mice (data
represent means6SEM; ZT12, WT, n=14 and Rev-KO, n=12;
ZT20, WT, n=8 and Rev-KO, n=8).
Found at: doi:10.1371/journal.pbio.1000181.s010 (0.45 MB EPS)
Figure S11 Temporal hepatic expression of E4bp4/Nfil3
transcripts in WT and E4bp4-KO mice, as monitored by
quantitative RT-PCR. Data represent the mean6SEM (n=4),
number values below detection level.
Found at: doi:10.1371/journal.pbio.1000181.s011 (0.29 MB EPS)
Table S1 Genes up-regulated in Rev-KO mice.
Found at: doi:10.1371/journal.pbio.1000181.s012 (0.03 MB XLS)
Table S2 Genes down-regulated in Rev-KO mice. In
Tables S1 and S2 the fold changes (FC) are the average ratios
between transcript accumulation levels (Rev-KO/WT) of all nine
comparisons (see experimental procedures for the analysis of
Affymetrix microarray data). The estimated fold changes were
verified by Northern blot (Nb) or quantitative RT-PCR experi-
ments. The minus signs in Table S2 indicate that these transcripts
accumulated to lower levels in Rev-KO mice than in WT mice.
Found at: doi:10.1371/journal.pbio.1000181.s013 (0.03 MB XLS)
Table S3 Nucleotide sequences of gene-specific primers
used in this study.
Found at: doi:10.1371/journal.pbio.1000181.s014 (0.02 MB XLS)
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